Publications by authors named "Ruby Birk"

Claim this Profile
A
A multicenter randomized, double-blind, placebo-controlled, parallel-group study to evaluate the effects of a 1-year regimen of orally inhaled fluticasone furoate 50 µg once daily on growth velocity in prepubertal, pediatric participants with well-controlled asthma.
Philippe Bareille, Varsha Imber, Jodie Crawford, Bernadetta Majorek-Olechowska, Zeina Karam-Absi, Ruby Birk

Pediatr Pulmonol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
2
24-Hour Serial Spirometric Assessment of Once-Daily Fluticasone Furoate/Umeclidinium/Vilanterol Versus Twice-Daily Budesonide/Formoterol in Patients with COPD: Analysis of the FULFIL Study.
David A Lipson, Ruby Birk, Noushin Brealey, Chang-Qing Zhu

Adv Ther· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population Pharmacokinetic Analysis of Fluticasone Furoate/Umeclidinium Bromide/Vilanterol in Patients with Chronic Obstructive Pulmonary Disease.
Rashmi Mehta, Colm Farrell, Siobhán Hayes, Ruby Birk, Malek Okour

Clin Pharmacokinet· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population Pharmacokinetic Analysis of Fluticasone Furoate/Umeclidinium/Vilanterol via a Single Inhaler in Patients with COPD.
Rashmi Mehta, Eleni Pefani, Misba Beerahee, Noushin Brealey, Helen Barnacle, Ruby Birk

J Clin Pharmacol· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preventing clinically important deterioration with single-inhaler triple therapy in COPD.
Ian Naya, Chris Compton, Afisi S Ismaila, Ruby Birk, Noushin Brealey

ERJ Open Res· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply to Morice and Hart: Increased Propensity for Pneumonia with Fluticasone in Chronic Obstructive Pulmonary Disease.
David A Lipson, Helen Barnacle, Ruby Birk, Noushin Brealey, Nicholas Locantore

Am J Respir Crit Care Med· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single-inhaler triple therapy in symptomatic COPD patients: FULFIL subgroup analyses.
David M G Halpin, Ruby Birk, Noushin Brealey, Gerard J Criner, Mark T Dransfield

ERJ Open Res· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply to Suissa and Ariel: The FULFIL Trial.
David A Lipson, Helen Barnacle, Ruby Birk, Noushin Brealey, Nicholas Locantore

Am J Respir Crit Care Med· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Once-Daily Triple Therapy in Patients with COPD: Patient-Reported Symptoms and Quality of Life.
Maggie Tabberer, David A Lomas, Ruby Birk, Noushin Brealey, Chang-Qing Zhu

Adv Ther· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single-inhaler fluticasone furoate/umeclidinium/vilanterol versus fluticasone furoate/vilanterol plus umeclidinium using two inhalers for chronic obstructive pulmonary disease: a randomized non-inferiority study.
Peter R Bremner, Ruby Birk, Noushin Brealey, Afisi S Ismaila, Chang-Qing Zhu

Respir Res· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply: "FULFIL an Unmet Need in Chronic Obstructive Pulmonary Disease" and "Triple Therapy in Chronic Obstructive Pulmonary Disease".
David A Lipson, Helen Barnacle, Ruby Birk, Noushin Brealey, Nicholas Locantore

Am J Respir Crit Care Med· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Once-Daily Triple Therapy in Patients with Advanced COPD: Healthcare Resource Utilization Data and Associated Costs from the FULFIL Trial.
Afisi S Ismaila, Ruby Birk, Dhvani Shah, Shiyuan Zhang, Noushin Brealey

Adv Ther· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FULFIL Trial: Once-Daily Triple Therapy for Patients with Chronic Obstructive Pulmonary Disease.
David A Lipson, Helen Barnacle, Ruby Birk, Noushin Brealey, Nicholas Locantore

Am J Respir Crit Care Med· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis